EUVIMEDEUVIMED entdecken
Fallbericht

First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1–5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major

Deepti Malik, Kiran Thakur, Rakesh Kumar, Bhupender Kumar, Jitender Singh, Sadhna Sharma

Cell Biochemistry and Biophysics · 2026

DOI: 10.1007/s12013-026-02003-5 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cell Biochemistry and Biophysics, 2026. Verfasst von Deepti Malik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, AIIMS Bilaspur, HP , India. dr.deepti.biochem@aiimsbilaspur.edu.in. Hauptthemen laut MEDLINE: beta-Thalassemia, Hemoglobins, Abnormal, beta-Globins. Die Arbeit nennt 26 Literaturangaben. Gefördert von: All-India Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beta-thalassemia (β-thalassemia) is one of the most common inherited hemoglobinopathy caused by mutations in the HBB gene and presents with a wide clinical spectrum ranging from asymptomatic to transfusion-dependent forms. We reported the first documented case of the rare Hb Oslo variant [HBB:c.127T >A; β42(CD1)Phe→Ile] in an Indian family and only the second reported case of Hb Oslo globally. Homology-based 3D structural modeling validated by Ramachandran plot, VERIFY3D, and PROCHECK indicated that Hb Oslo variant disrupts key hydrophobic interactions within the β-globin heme pocket, likely compromising heme stabilization and oxygen-binding efficiency. In addition to Hb Oslo variant, we identified the IVS1–5G >C [HBB:c.92+5G >C] splicing mutation in two siblings from a single Indian family, resulting in a novel compound heterozygous combination of two HBB gene mutations: IVS1–5G >C and Hb Oslo [HBB:c.127T >A] detected through ARMS-PCR and Sanger sequencing. Parental segregation showed that the father carried only the IVS1-5G > C mutation and remained clinically transfusion independent, whereas both siblings carried IVS1–5G >C and Hb Oslo mutations, exhibited a transfusion-dependent phenotype. These findings suggest that while each variant alone is typically associated with a mild or carrier phenotype in the heterozygous state, their co-inheritance was associated with a phenotypic shift from non–transfusion-dependent thalassemia (NTDT) to transfusion-dependent thalassemia (TDT) suggesting that co-inheritance of these mutation may aggravate the severity of beta thalassemia. This is the first report of such a genetic combination providing new insights into the complex genotype-phenotype correlation in β-thalassemia.These findings emphasize the importance of comprehensive molecular screening, genetic counseling and prenatal diagnosis in high-prevalence regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaHemoglobins, Abnormalbeta-GlobinsHumansIndiaHeterozygoteMutationMaleFemaleModels, MolecularPedigree

Stichwörter der Autor:innen

HBB geneARMS-PCRCarrier screeningHb OsloSanger sequencingβ-thalassemia

Substanzen

Hemoglobins, Abnormalbeta-Globins

Autor:innen und Institutionen

  • Department of Biochemistry, AIIMS Bilaspur, HP , India. dr.deepti.biochem@aiimsbilaspur.edu.in.
  • Department of Biochemistry, AIIMS Bilaspur, HP , India.
  • Department of Transfusion Medicine, AIIMS Bilaspur , HP, India.
  • Department of Internal Medicine, AIIMS Bilaspur , HP , India.
  • Department of Paediatric Surgery, APC, PGIMER, Chandigarh, Chandigarh, India.

Förderung

  • All-India Institute of Medical Sciences

Zitieren

APA

Malik, D., Thakur, K., Kumar, R., Kumar, B., Singh, J., & Sharma, S. (2026). First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1–5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-026-02003-5

Vancouver

Malik D, Thakur K, Kumar R, Kumar B, Singh J, Sharma S. First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1–5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major. Cell Biochemistry and Biophysics. 2026. doi:10.1007/s12013-026-02003-5

BibTeX
@article{Malik2026,
  author = {Malik, Deepti and Thakur, Kiran and Kumar, Rakesh and Kumar, Bhupender and Singh, Jitender and Sharma, Sadhna},
  title = {First Report of Hb Oslo [HBB:c.127T>A; β42(CD1)Phe→Ile] from India and its Novel Compound Heterozygous Combination with IVS1–5 G>C [HBB:c.92+ 5G> C] Leading To β-Thalassemia Major},
  journal = {Cell Biochemistry and Biophysics},
  year = {2026},
  doi = {10.1007/s12013-026-02003-5}
}
Kostenlos starten →